Mark R. Morgan

2.6k total citations
42 papers, 2.2k citations indexed

About

Mark R. Morgan is a scholar working on Cell Biology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Mark R. Morgan has authored 42 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cell Biology, 19 papers in Immunology and Allergy and 12 papers in Molecular Biology. Recurrent topics in Mark R. Morgan's work include Cell Adhesion Molecules Research (19 papers), Cellular Mechanics and Interactions (14 papers) and Proteoglycans and glycosaminoglycans research (10 papers). Mark R. Morgan is often cited by papers focused on Cell Adhesion Molecules Research (19 papers), Cellular Mechanics and Interactions (14 papers) and Proteoglycans and glycosaminoglycans research (10 papers). Mark R. Morgan collaborates with scholars based in United Kingdom, United States and Japan. Mark R. Morgan's co-authors include Martin J. Humphries, Mark D. Bass, Adam Byron, Christoph Ballestrem, Jonathan D. Humphries, Chris Baylis, John C. Atherton, G. M. Wyatt, John F. Marshall and Zohreh Mostafavi‐Pour and has published in prestigious journals such as The Lancet, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Mark R. Morgan

41 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Morgan United Kingdom 23 985 949 725 345 247 42 2.2k
Mark D. Bass United Kingdom 23 1.4k 1.4× 1.1k 1.2× 902 1.2× 217 0.6× 181 0.7× 33 2.4k
Mercedes Costell Spain 31 1.3k 1.4× 1.4k 1.5× 976 1.3× 366 1.1× 221 0.9× 57 3.2k
Alan J. Russell United States 23 784 0.8× 1.2k 1.3× 506 0.7× 359 1.0× 122 0.5× 64 2.4k
Sarita K. Sastry United States 16 860 0.9× 1.1k 1.2× 941 1.3× 202 0.6× 155 0.6× 21 2.1k
Karen H. Martin United States 27 1.0k 1.1× 1.6k 1.6× 1.0k 1.4× 419 1.2× 211 0.9× 59 3.0k
William D. Staatz United States 21 851 0.9× 1.2k 1.3× 899 1.2× 345 1.0× 82 0.3× 28 2.6k
Xiang-Dong Ren United States 18 1.6k 1.7× 1.9k 2.0× 984 1.4× 245 0.7× 359 1.5× 28 3.6k
Geraldine M. O’Neill Australia 32 1.1k 1.1× 1.7k 1.8× 693 1.0× 327 0.9× 240 1.0× 78 3.0k
Su Hao Lo United States 32 1.2k 1.2× 1.8k 1.9× 1.2k 1.6× 420 1.2× 112 0.5× 80 3.2k
Julia Thom Oxford United States 30 379 0.4× 1.1k 1.2× 419 0.6× 263 0.8× 218 0.9× 106 2.9k

Countries citing papers authored by Mark R. Morgan

Since Specialization
Citations

This map shows the geographic impact of Mark R. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Morgan more than expected).

Fields of papers citing papers by Mark R. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Morgan. The network helps show where Mark R. Morgan may publish in the future.

Co-authorship network of co-authors of Mark R. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Morgan. A scholar is included among the top collaborators of Mark R. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Morgan. Mark R. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fielding, Andrew B., et al.. (2025). OTUD6B regulates KIFC1-dependent centrosome clustering and breast cancer cell survival. EMBO Reports. 26(4). 1003–1035. 1 indexed citations
2.
Gamage, Sujani Madhurika Kodagoda, et al.. (2024). Internal evaluation of medical programs is more than housework: A scoping review. PLoS ONE. 19(10). e0305996–e0305996.
3.
Rigby, M., Justine Webster, Jun Wang, et al.. (2024). A trafficking regulatory subnetwork governs α V β 6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance. Science Advances. 10(49). eadk9944–eadk9944. 4 indexed citations
4.
MacDonald, Ewan, Arthur Charles‐Orszag, Benjamin T. Goult, et al.. (2023). 3D matrix adhesion feedback controls nuclear force coupling to drive invasive cell migration. Cell Reports. 42(12). 113554–113554. 10 indexed citations
5.
Barker, Harlan, Ulrike May, Stuart Prince, et al.. (2023). Systemically administered wound-homing peptide accelerates wound healing by modulating syndecan-4 function. Nature Communications. 14(1). 8069–8069. 13 indexed citations
6.
Panieri, Emiliano, Ralph T. Böttcher, Elena Astanina, et al.. (2016). PPFIA1 drives active α5β1 integrin recycling and controls fibronectin fibrillogenesis and vascular morphogenesis. Nature Communications. 7(1). 13546–13546. 66 indexed citations
7.
Humphries, Jonathan D., Nikki R. Paul, Martin J. Humphries, & Mark R. Morgan. (2015). Emerging properties of adhesion complexes: what are they and what do they do?. Trends in Cell Biology. 25(7). 388–397. 64 indexed citations
8.
Jacquemet, Guillaume, Mark R. Morgan, Adam Byron, et al.. (2013). Rac1 is deactivated at integrin activation sites via an IQGAP1/filamin-A/RacGAP1 pathway. Journal of Cell Science. 126(Pt 18). 4121–35. 55 indexed citations
9.
Morgan, Mark R., Hellyeh Hamidi, Mark D. Bass, et al.. (2013). Syndecan-4 Phosphorylation Is a Control Point for Integrin Recycling. Developmental Cell. 24(5). 472–485. 109 indexed citations
10.
Bass, Mark D., Rosalind C. Williamson, Robert Nunan, et al.. (2011). A Syndecan-4 Hair Trigger Initiates Wound Healing through Caveolin- and RhoG-Regulated Integrin Endocytosis. Developmental Cell. 21(4). 681–693. 109 indexed citations
11.
Morgan, Mark R., Alan G. Ramsay, Gareth J. Thomas, et al.. (2010). Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion. Oncogene. 30(12). 1422–1435. 28 indexed citations
12.
Byron, Adam, Mark R. Morgan, & Martin J. Humphries. (2010). Adhesion signalling complexes. Current Biology. 20(24). R1063–R1067. 38 indexed citations
13.
Morgan, Mark R., Adam Byron, Martin J. Humphries, & Mark D. Bass. (2009). Giving off mixed signals—Distinct functions of α5β1 and αvβ3 integrins in regulating cell behaviour. IUBMB Life. 61(7). 731–738. 88 indexed citations
14.
Bass, Mark D., et al.. (2008). p190RhoGAP is the convergence point of adhesion signals from α5β1 integrin and syndecan-4. The Journal of Cell Biology. 181(6). 1013–1026. 92 indexed citations
15.
Morgan, Mark R., Martin J. Humphries, & Mark D. Bass. (2007). Synergistic control of cell adhesion by integrins and syndecans. Nature Reviews Molecular Cell Biology. 8(12). 957–969. 466 indexed citations
16.
Bass, Mark D., Mark R. Morgan, & Martin J. Humphries. (2007). Integrins and syndecan-4 make distinct, but critical, contributions to adhesion contact formation. Soft Matter. 3(3). 372–372. 34 indexed citations
17.
Thomas, Gareth J., John F. Marshall, Mark R. Morgan, et al.. (2004). Modulation of the urokinase-type plasminogen activator receptor by the β6 integrin subunit. Biochemical and Biophysical Research Communications. 317(1). 92–99. 17 indexed citations
18.
Zhu, Gang, R Gilchrist, Mark R. Morgan, et al.. (2004). Reduction of TSG101 protein has a negative impact on tumor cell growth. International Journal of Cancer. 109(4). 541–547. 48 indexed citations
19.
Morgan, Mark R., Gareth J. Thomas, Alan J. Russell, Ian R. Hart, & John F. Marshall. (2004). The Integrin Cytoplasmic-tail Motif EKQKVDLSTDC Is Sufficient to Promote Tumor Cell Invasion Mediated by Matrix Metalloproteinase (MMP)-2 or MMP-9. Journal of Biological Chemistry. 279(25). 26533–26539. 44 indexed citations
20.
Evans, Sydney M., Stephen M. Hahn, W. Timothy Jenkins, et al.. (2000). Detection of hypoxia in human squamous cell carcinoma by EF5 binding.. PubMed. 60(7). 2018–24. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026